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Background.– Current prescribing information recommends botulinum toxin
(BoNT) treatment intervals for cervical dystonia (CD) ≥ 12 weeks (≥ 10 weeks
for incobotulinumtoxinA European labelling). However, many patients expe-
rience recurrence of symptoms before 12 weeks have elapsed.
Methods.– A cross-sectional survey of patients with CD collected data on BoNT
treatment intervals received and preferred intervals [1]. These were compared
with intervals from an incobotulinumtoxinA clinical study in CD where patients
were re-injected at flexible intervals ≥ 6 weeks based on patients’ requests and
investigator-confirmed clinical need for retreatment [2].
Results.– Most (78.4%) patients in the survey (n = 136) preferred treat-
ment intervals ≤ 12 weeks; 46.3% preferred intervals ≤ 10 weeks. However,
47.1% of survey patients received intervals ≤ 12 weeks; 4.4% received inter-
vals ≤ 10 weeks. In the clinical study, 821 incobotulinumtoxinA treatments were
given at intervals of 6–20 weeks; 44.9% of treatments were given at intervals.
Conclusions.– Many patients with CD would like individualised BoNT treatment
regimens. When flexible treatment intervals are permitted, many patients choose
shorter or longer intervals than the 12-week standard-of-care interval.
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Background.– Intrathecal baclofen (ITB) infusion has become a common treat-
ment for severe spasticity. Many complications of these drug delivery systems
have been reported, such as those related to improper dosing, mechanical failure
of the implanted pump or catheter, or postoperative wound issues.
Results.– A 47-year-old man, with spastic paraplegia due to D4 ASIA A spinal
cord injury and right upper brachial plexus lesion, with a double barrel colostomy
to heal a perineal pressure sore, presented an abdominal wound dehiscence with
partial exposure of the ITB pump (350g/day, continuous), associated with signs
and symptoms of acute baclofen withdrawal, and eventual sepsis. As a result,
the patient underwent removal of the baclofen infusion system, closure with
plastic skin surgery, and placement of a new ITB infusion system (Synchromed
II, Medtronic), with the pump placed in the right abdominal region.
Conclusions.– Patients with baclofen pumps require periodic monitoring, not
only by the need to fill the pump, but also to assess the risk of complications
related to dosing or mechanical implant dysfunction, which can be serious
and life-threatening. It is important to inform patients about possible risks and
complications of this device in order to be aware of warning symptoms.
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Background.– We evaluated whether patients with longstanding upper extremity
(UE) post-stroke spasticity gain functional improvements through task-oriented
rehabilitation therapy combined with Xeomin (incobotulinumtoxinA) injec-
tions.
Methods.– Eleven consecutive patients (aged 37–80 years) with UE spasti-
city ≥ 2 years post-stroke (mean, 6.2 years; range, 2–24 years) and a Modified
Ashworth Scale (MAS) score > 3 for two joints received conventional rehabili-
tation therapy combined with Xeomin (three treatments per year administered
by the same physician using electromyographic guidance). Xeomin dose (target
range 130–400 U) and injected muscles depended on UE muscles involved. Out-
come measures included Disability Assessment Scale (DAS), muscle tone (using
MAS) and range of motion (ROM), assessed before and 1, 6 and 12 months after
the first Xeomin treatment.
Results.– After one year of rehabilitation therapy and Xeomin treatments, mean
DAS score improved from 1.6 to 0.9, mean MAS score decreased from 3.3 to 1.8
and mean ROM score increased from –22.5 to –7.7 (P < 0.0001 for all; ANOVA).
No adverse events occurred.
Conclusions.– In patients with longstanding UE post-stroke spasticity, Xeomin
combined with conventional rehabilitation therapy improved disability, muscle
tone and ROM and was well tolerated. Activities of daily living were improved
after the paralytic effects of Xeomin had largely diminished.
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Background.– Sonoelastography (SE), which is an ultrasound-based technique,
can assess tissue elasticity. The objective of the study is to assess forearm muscles
spasticity in patients with stroke.
Methods.– Twenty-three stroke patients (17 males %73,9; 6 females %26,1) who
had spasticity in forearm muscles (pronator teres, flexor carpi radialis, flexor
carpi ulnaris, flexor digitorum superficialis, flexor carpi ulnaris) were evaluated
with ultrasonography. Elasticity Index (E), which indicates the tissue elasticity,
was measured using SE. E value ranged from 0 to 6 (6 indicates hardest tissue).
The bulkiest part of the muscles in short axis was targeted for the measurement.
SE findings in affected side were compared with unaffected side.
Results.– E values and E ratio were higher in affected forearm muscles compared
to unaffected forearm muscles (P < 0.05).
Conclusions.– The results of the study suggested that SE could be used to assess
spasticity in forearm muscles.
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